SCHEMBL2014186

SCHEMBL2014186

CN(C(=O)c1nccc2ccccc12)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.60
HCRTR2 O43614 2/20 0.60
RAB9A P51151 3/20 0.47
NPC1 O15118 2/20 0.47
PADI4 Q9UM07 3/20 0.40
CCR1 P32246 1/20 0.38
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
HRH3 Q9Y5N1 2/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
HDAC5 Q9UQL6 1/20 0.36
ITGB1 P05556 1/20 0.36
ITGA4 P13612 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2012754 0.86 HCRTR1 (0.62) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2011844 0.84 HCRTR1 (0.60) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2054308 0.84 HCRTR1 (0.60) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2014566 0.84 HCRTR1 (0.64) HCRTR1HCRTR2RAB9ACCR1ITGB1
SCHEMBL2054138 0.84 HCRTR1 (0.64) HCRTR1HCRTR2RAB9ACCR1ITGB1
SCHEMBL2013351 0.84 HCRTR1 (0.58) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2013812 0.83 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2012839 0.83 HCRTR1 (0.59) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2015468 0.83 HCRTR1 (0.58) HCRTR1HCRTR2RAB9ANPC1PADI4
SCHEMBL2014804 0.83 HCRTR1 (0.58) HCRTR1HCRTR2RAB9ANPC1PADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed